S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
Log in
NASDAQ:ANGO

AngioDynamics Stock Forecast, Price & News

$18.55
+0.35 (+1.92 %)
(As of 01/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$17.63
Now: $18.55
$18.60
50-Day Range
$13.77
MA: $16.11
$19.10
52-Week Range
$7.48
Now: $18.55
$19.90
Volume338,859 shs
Average Volume446,451 shs
Market Capitalization$704.04 million
P/E RatioN/A
Dividend YieldN/A
Beta0.89
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides vascular interventions and therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
AngioDynamics logo

MarketRank

Overall MarketRank

1.65 out of 5 stars

Medical Sector

262nd out of 1,922 stocks

Surgical & Medical Instruments Industry

23rd out of 168 stocks

Analyst Opinion: 2.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ANGO
CUSIP03475V10
Phone518-795-1400
Employees800
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$264.16 million
Cash Flow$0.75 per share
Book Value$12.09 per share

Profitability

Net Income$-166,790,000.00

Miscellaneous

Market Cap$704.04 million
Next Earnings Date4/6/2021 (Estimated)
OptionableOptionable
$18.55
+0.35 (+1.92 %)
(As of 01/25/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ANGO News and Ratings via Email

Sign-up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AngioDynamics (NASDAQ:ANGO) Frequently Asked Questions

How has AngioDynamics' stock been impacted by Coronavirus?

AngioDynamics' stock was trading at $10.14 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ANGO shares have increased by 82.9% and is now trading at $18.5450.
View which stocks have been most impacted by COVID-19
.

Is AngioDynamics a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AngioDynamics in the last year. There are currently 1 hold rating and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" AngioDynamics stock.
View analyst ratings for AngioDynamics
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than AngioDynamics?

Wall Street analysts have given AngioDynamics a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but AngioDynamics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is James C. Clemmer's approval rating as AngioDynamics' CEO?

27 employees have rated AngioDynamics CEO James C. Clemmer on Glassdoor.com. James C. Clemmer has an approval rating of 50% among AngioDynamics' employees. This puts James C. Clemmer in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is AngioDynamics' next earnings date?

AngioDynamics is scheduled to release its next quarterly earnings announcement on Tuesday, April 6th 2021.
View our earnings forecast for AngioDynamics
.

How were AngioDynamics' earnings last quarter?

AngioDynamics, Inc. (NASDAQ:ANGO) announced its earnings results on Wednesday, January, 6th. The medical instruments supplier reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.03. The medical instruments supplier had revenue of $72.80 million for the quarter, compared to the consensus estimate of $67.33 million. AngioDynamics had a negative trailing twelve-month return on equity of 0.12% and a negative net margin of 62.82%. The business's revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.06 earnings per share.
View AngioDynamics' earnings history
.

What guidance has AngioDynamics issued on next quarter's earnings?

AngioDynamics updated its FY21 earnings guidance on Thursday, January, 7th. The company provided earnings per share (EPS) guidance of $0.00-0.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.02. The company issued revenue guidance of $278-284 million, compared to the consensus revenue estimate of $281.53 million.

What price target have analysts set for ANGO?

2 analysts have issued 1 year price objectives for AngioDynamics' shares. Their forecasts range from $18.00 to $24.00. On average, they anticipate AngioDynamics' share price to reach $21.00 in the next twelve months. This suggests a possible upside of 13.2% from the stock's current price.
View analysts' price targets for AngioDynamics
or view Wall Street analyst' top-rated stocks.

Are investors shorting AngioDynamics?

AngioDynamics saw a decrease in short interest during the month of December. As of December 31st, there was short interest totaling 844,900 shares, a decrease of 21.8% from the December 15th total of 1,080,000 shares. Based on an average trading volume of 299,100 shares, the short-interest ratio is presently 2.8 days. Currently, 2.3% of the shares of the stock are short sold.
View AngioDynamics' Short Interest
.

Who are some of AngioDynamics' key competitors?

What other stocks do shareholders of AngioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AngioDynamics investors own include General Electric (GE), Intel (INTC), (OAS), Advanced Micro Devices (AMD), Freeport-McMoRan (FCX), Amicus Therapeutics (FOLD), Rigel Pharmaceuticals (RIGL), Accuray (ARAY), Celldex Therapeutics (CLDX) and Chimerix (CMRX).

Who are AngioDynamics' key executives?

AngioDynamics' management team includes the following people:
  • Mr. James C. Clemmer, CEO, Pres & Director (Age 57, Pay $1.33M)
  • Mr. Stephen A. Trowbridge, Exec. VP & CFO (Age 47, Pay $629.55k)
  • Mr. David D. Helsel, Sr. VP of Global Operations and R&D (Age 57, Pay $522.12k)
  • Mr. Scott Centea, Sr. VP & GM of Vascular Interventions and Therapies & Peripheral Artery Disease (Age 43, Pay $558.54k)
  • Mr. Benjamin H. Davis, Sr. VP of Bus. Devel. (Age 57)
  • Ms. Marna I. Bronfen-Moore, Sr. VP of HR (Age 54)
  • Mr. Chad T. Campbell, Sr. VP & GM of Vascular Access Global Bus. Unit (Age 50)
  • Mr. Warren G. Nighan, Sr. VP of Quality & Regulatory Affairs (Age 52)
  • Ms. Kim L. Seabury, Sr. VP of Information Technology (Age 54)

What is AngioDynamics' stock symbol?

AngioDynamics trades on the NASDAQ under the ticker symbol "ANGO."

Who are AngioDynamics' major shareholders?

AngioDynamics' stock is owned by a variety of retail and institutional investors. Top institutional investors include Paradigm Capital Management Inc. NY (0.50%), Candriam Luxembourg S.C.A. (0.27%), Wedge Capital Management L L P NC (0.23%), Exchange Traded Concepts LLC (0.08%), State of Alaska Department of Revenue (0.08%) and Diversified Trust Co (0.03%). Company insiders that own AngioDynamics stock include James C Clemmer, Kevin J Gould, Stephen A Trowbridge and Wesley Johnson.
View institutional ownership trends for AngioDynamics
.

Which major investors are selling AngioDynamics stock?

ANGO stock was sold by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., State of Alaska Department of Revenue, and First Citizens Bank & Trust Co..
View insider buying and selling activity for AngioDynamics
or view top insider-selling stocks.

Which major investors are buying AngioDynamics stock?

ANGO stock was bought by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Paradigm Capital Management Inc. NY, Diversified Trust Co, and Exchange Traded Concepts LLC. Company insiders that have bought AngioDynamics stock in the last two years include James C Clemmer, and Stephen A Trowbridge.
View insider buying and selling activity for AngioDynamics
or or view top insider-buying stocks.

How do I buy shares of AngioDynamics?

Shares of ANGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AngioDynamics' stock price today?

One share of ANGO stock can currently be purchased for approximately $18.55.

How big of a company is AngioDynamics?

AngioDynamics has a market capitalization of $704.04 million and generates $264.16 million in revenue each year. The medical instruments supplier earns $-166,790,000.00 in net income (profit) each year or $0.09 on an earnings per share basis. AngioDynamics employs 800 workers across the globe.

What is AngioDynamics' official website?

The official website for AngioDynamics is www.angiodynamics.com.

How can I contact AngioDynamics?

AngioDynamics' mailing address is 14 PLAZA DRIVE, LATHAM NY, 12110. The medical instruments supplier can be reached via phone at 518-795-1400 or via email at [email protected]

This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.